Search Within

Dmitriy Zamarin

  1. "GSK Faculty"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (31)
  3. Book Section (1)
  4. Editorial (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (75)
  2. GDMT, Medicine (75)
  3. GSK Faculty (75)
  4. Gynecologic Medicine Service (75)
  5. Gynecology Disease Management Team (75)
  6. Solid Tumor Oncology Division (75)

More Groups

People
  1. Jedd Wolchok (34)
  2. Britta Weigelt (31)
  3. Taha Merghoub (29)
  4. Carol Aghajanian (18)
  5. Jorge Reis-Filho (17)
  6. Nadeem Abu-Rustum (17)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (15)
  4. 2021 (5)
  5. 2020 (15)
  6. 2019 (3)

More Years

Publications
  1. Gynecologic Oncology (11)
  2. Journal for ImmunoTherapy of Cancer (9)
  3. Journal of Clinical Oncology (8)
  4. Cancer Research (4)
  5. Clinical Cancer Research (4)
  6. Nature (4)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. Elsevier Inc. (12)
  3. Nature Publishing Group (11)
  4. American Society of Clinical Oncology (9)
  5. Biomed Central Ltd (9)
  6. Cell Press (6)

More Publishers

Results (75)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase and T-cell based anti-tumor immunotherapies targeting immune checkpoints
    Meeting Abstract

    Holmgaard, R.; Zamarin, D.; Munn, D.; Wolchok, J.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Genetically engineered oncolytic newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
    Journal Article

    Silberhumer, G. R.; Brader, P.; Wong, J.; Serganova, I. S.; Gonen, M.; González, S. J.; Blasberg, R.; Zamarin, D.; Fong, Y.
    Molecular Cancer Therapeutics (2010)

    Fulltext@MSK | Save
  • Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma
    Meeting Abstract

    Silberhumer, G.; Brader, P.; Wong, J.; Zamarin, D.; Serganova, I.; Blasberg, R.; Palese, P.; Fong, Y.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save